ClassID:

20287

A61K31/34 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Recent Application in this class:
#601
20060110469
2006-05-25

Angelicae sinensis extracts useful for treatment of cancers

#602
20060100271
2006-05-11

Stabilized aqueous ranitidine compositions

#603
20060100210
2006-05-11

Methods for treatment of scleroderma

#604
20060100167
2006-05-11

Methods and compositions for the treatment of autoimmune disorders using clofarabine

#605
20060099170
2006-05-11

Compositions for inducing increased levels of beta-chemokines and methods of use therefor

#606
20060089350
2006-04-27

Methods and compositions for the treatment of neuropsychiatric disorders

#607
20060078594
2006-04-13

Iron complex

#608
20060058376
2006-03-16

Composition having autonomic nerve modulating activity and method of use thereof

#609
20060019955
2006-01-26

Oculoselective drugs and prodrugs

#610
20060014829
2006-01-19

Methods for reducing hospitalizations related to heart failure

#611
20060014828
2006-01-19

Compositions and methods related to heart failure

#612
20060014784
2006-01-19

Compounds for the treatment of metabolic disorders

#613
20060003002
2006-01-05

Pharmaceutical compositions with synchronized solubilizer release

#614
20050282910
2005-12-22

Methods of application of chemical compounds having therapeutic activities in treating cancers

#615
20050281820
2005-12-22

Compositions and methods for treating burns

#616
20050274391
2005-12-15

Means for weaning people off smoking and alcohol

#617
20050261369
2005-11-24

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#618
20050261328
2005-11-24

Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents

#619
20050256193
2005-11-17

Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity

#620
20050255156
2005-11-17

Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

#621
20050239877
2005-10-27

Synthetic lactone formulations and method of use

#622
20050233008
2005-10-20

Comprehensive pharmacologic therapy for treatment of a dysfunction

#623
20050232988
2005-10-20

Orally disintegrating tablets and methods of manufacture

#624
20050222251
2005-10-06

Dual inhibition of cyclooxygenase-2 and carbonic anhydrase

#625
20050214366
2005-09-29

Anti-first-pass effect compounds

#626
20050203077
2005-09-15

Selenophene anti-tumor agents

#627
20050197300
2005-09-08

Microdose therapy

#628
20050187261
2005-08-25

Hydroxamates as therapeutic agents

#629
20050171166
2005-08-04

Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases

#630
20050159491
2005-07-21

Preparation and application of transhintotalphenolic acid

#631
20050158713
2005-07-21

Fitness assay and associated methods

#632
20050158325
2005-07-21

Immunomodulatory combinations

#633
20050143467
2005-06-30

Stimulation of cpt-1 as a means to reduce weight

#634
20050136127
2005-06-23

Gastrointestinal compositions

#635
20050131028
2005-06-16

Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders

#636
20050124684
2005-06-09

5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production

#637
20050119337
2005-06-02

Methods of application of Schisandrin B in the preparation of anticancer medications

#638
20050107350
2005-05-19

Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith

#639
20050106217
2005-05-19

Stimulation of CPT-1 as a means to reduce weight

#640
20050101659
2005-05-12

Treating sickle cell disease

#641
20050101642
2005-05-12

Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist

#642
20050100538
2005-05-12

Intradiscal injection of anti-oxidants

#643
20050096371
2005-05-05

Topical pharmaceutical compositions

#644
20050096365
2005-05-05

Pharmaceutical compositions with synchronized solubilizer release

#645
20050096296
2005-05-05

Pharmaceutical compositions with synchronized solubilizer release

#646
20050090538
2005-04-28

Analgesic and anti-inflammatory compositions containing Cox-2-inhibitors

#647
20050080299
2005-04-14

Method for the preparation of matairesinol

#648
20050075391
2005-04-07

Nitric oxide donor composition and method for treatment of anal disorders

#649
20050065190
2005-03-24

Comprehensive pharmacologic therapy for treatment of obesity including cysteine

#650
20050049204
2005-03-03

Compounds for the treatment of flaviviridae infections

#651
20050032713
2005-02-10

Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents

#652
20050020673
2005-01-27

Method for the preparation of lariciresinol cyclolariciresinol and secoisolariciresinol

#653
20050020672
2005-01-27

Methods of extending mammalian life span via iron chelating compounds that reduce free radical damage in mammals

#654
15671742
2019-07-02

Method for topical treatment of nail conditions

#655
15671732
2019-02-19

Method for treating fungal infections in nails